[Ip-health] Save the Date: MSF/TAG Symposium at TB Union Conference, Cape Town - Ending TB in India: Why civil society should dream and act BIG?, 4 December, 17:15-18:30 hrs
Michelle.French at newyork.msf.org
Thu Nov 5 22:59:16 PST 2015
Ending TB in India: Why civil society should dream and act BIG?
4 December, 17:15-18:30 hrs
46th Union World Conference on Lung Health, Cape Town, South Africa
India contributes more than a quarter of the global cohort of TB patients
and ranks first among the 27 MDR-TB high-burden countries. If the targets
of the END TB strategy are to be reached, significant improvements and
radical changes are urgently needed. Universal access to new and existing
diagnostics is moving slowly, novel treatment modalities for MDR-TB are
not being offered (e.g shorter regimens, new drugs), patient-centered
approaches have not been defined as yet and there is a lack of innovation
in the R&D agenda despite India’s research and funding potential. The
Indian civil society can play an important catalyst for speeding up the
‘end of TB’ in the country.
Médecins Sans Frontières Access Campaign and Treatment Action Group
cordially invites attendees of the 46th Union World Conference on Lung
Health being held in Cape Town, 2-6th Dec to participate and deliberate at
our Symposium on active engagement of civil society in achieving goals of
the End TB strategy in India. The symposium will focus on new developments
and policy changes in India’s national TB program, implementation gaps,
the need for further research and development and the need for access to
newer and better dugs and diagnostics. The symposium will attempt to find
answers to some of the questions that civil society continue to grapple
with such as…..
· What role can civil society play in bridging the wide gap between
policy changes and implementation on the ground?
· How can the role of community networks and civil society be expanded
from service delivery to active advocacy for patient’s rights?
· How can civil society act as a catalyst for speeding up the ‘end of
TB’ in India?
Jennifer Furin, Tuberculosis Research Unit, Case Western Reserve
Grania Brigden, Médecins Sans Frontières Access Campaign
Zarir F Udwadia, Hinduja Hospital
Mike Frick, Treatment Action Group
Tsetan Dorji Sadutshang, Tibetan Delek Hospital
Homa Mansoor, Médecins Sans Frontières
Elizabeth Selhore, Sahara Aalhad
For more details, please contact:
Petros Isaakidis @ msfocb-asia-epidemio at brussels.msf.org / +91-9930534211
Shailly Gupta @ shailly.gupta at msf.org/+91-9899976108
Sr. Communications Manager, MSF Access Campaign
Doctors Without Borders\Médecins Sans Frontières (MSF)
Office: +1.212.763.5735 | Mobile: +1.646.552.4600
michelle.french at newyork.msf.org | Skype: michellejfrench
www.msfaccess.org | twitter.com/MSF_access | www.facebook.com/MSFaccess
More information about the Ip-health